Sirnaomics (HKG:2257) agreed to issue 17.35 million new shares at HK$12.00 each to four subscribers, raising about HK$206 million in net proceeds, according to a Monday Hong Kong bourse filing.
The subscription price represents a 19.8% discount to the Sept. 5 closing price of HK$14.97 but a nearly 1.6% premium to the five-day average.
The new shares equal 16.5% of the existing issued capital and will dilute to about 14.2% after completion.
Hong Kong unit of Shanghai-listed Bloomage Biotechnology (SHA:688363) will take 11.57 million shares and may nominate two directors to Sirnaomics' board.
The other investors include executive Tse Shek Ho and two private individuals through BVI entities.
Net proceeds will be used for general working capital.
Comments